National Cancer Institute, Research Contracts Branch, PSCS, 6120 Executive Blvd, Eps/room 638, Bethesda, MD 20892-7227

A -- RESEARCH & DEVELOPMENT SOL NCI-RFQ-70159(NQ) DUE 090997 POC Cynthia Brown, Purchasing Agent, 301-402-4509, Trish Haun, Contracting Officer The National Inst. of Health, National Cancer Institute, Division of Cancer Epidemiology & Genetics Environmental Epidemiology Branch, intends to issue a sole source RFQ to Quest Diagnostics, 33608 Ortega Highway, San Juan Capistrano, Ca. The purpose is to continue a study to assess benign breast disease and breast cancer case-control differences in serum levels of three androgens, namely testosterone, androstenedione, and DHEA. The study now includes 190 breast cancer cases, 190 cases with hyperplastic benign breast disease, 190 benign controls with non-hyperplastic breast disease and 57 quality control samples, for a total of 627 samples. The study formerly included samples from 487 women. It is essential that the assays for the additional 140 women be performed by the same lab that is performing the assays for the original 487 samples. This is not a request for competitive proposals, as no solicitation will be issued. However, vendors who believe they can meet the Governments requirements may submit their qualifications. The submission must be in writing and must contain sufficient detail so that a determination can be made regarding meeting the Governments requirements. The submission must be received by the COB 09/09/97. (0232)

Loren Data Corp. http://www.ld.com (SYN# 0003 19970822\A-0003.SOL)